COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Thumbnail

Biden administration announces new actions to help hospitals keep up with omicron

The feds are making a large push to expand testing, setting up new sites across the U.S. and sending 500 million free kits to Americans beginning Jan. 1.

CDC now recommends Moderna, Pfizer/BioNTech COVID-19 vaccines over Johnson & Johnson’s due to risk of fatal blood clots

Johnson & Johnson’s vaccine has been associated with an elevated risk of thrombosis with thrombocytopenia syndrome.

Cardiologist interviewed by Joe Rogan claims U.S. withheld early COVID-19 treatments to promote fear, push support for vaccines

Peter A. McCullough, MD, has been no stranger to controversy during the ongoing pandemic. 

covid-19 money virus coronavirus dollar

American Heart Association investing $10 million to study the long-term consequences of COVID-19

Researchers have until Feb. 1 to apply for one of the group's new COVID-19 research grants. 

Cardiovascular surgeon wants to sue hospital after he was fired for refusing COVID-19 vaccine

The hospital's former chief of cardiovascular surgery is now raising money online so that he can pursue legal action. 

JPMorgan moves annual healthcare conference online following omicron concerns

Biotech giants Moderna and Amgen both recently dropped out of the in-person meeting, which was set to take place next month in San Francisco.

Thumbnail

Pfizer says its pill remains 89% effective against COVID-19 in final study results

The health giant also noted that the antiviral worked in lab studies against the omicron variant.

Assessing blood samples with new device pinpoints early warning signs for COVID-19 patients

The researchers found an unusually high amount of platelet aggregation in patient samples, a known indicator of microvascular thrombosis.